|
Market Closed -
Bombay S.E.
14:02:23 12/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 530.15 INR | +0.10% |
|
-0.30% | +20.12% |
| Market Cap | 37.33B 390M 350M 326M 296M 557M 561M 3.92B 1.53B 19.26B 1.47B 1.43B 61.98B | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 39.43B 413M 369M 344M 312M 589M 593M 4.14B 1.62B 20.35B 1.55B 1.52B 65.48B | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.74% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| UNICHEMLAB | Delayed | |
NSE India S.E.
| UNICHEMLAB | Delayed |
| 1 day | +0.10% | ||
| 1 week | -0.30% | ||
| Current month | -2.97% | ||
| 1 month | +1.83% | ||
| 3 months | -11.21% | ||
| 6 months | +57.27% | ||
| Current year | +20.12% |
| 1 week | 520 |  | 568.75 |
| 1 month | 499.25 | | 604 |
| Current year | 280 | | 685.95 |
| 1 year | 280 | | 685.95 |
| 3 years | 280 | | 949.85 |
| 5 years | 197.5 | | 949.85 |
| 10 years | 75.1 | | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 08/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 22/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 10/08/2023 |
| Director/Board Member | 57 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.10% | -0.30% | +11.12% | +25.75% | 385M | |
| +0.13% | +3.15% | +43.91% | +93.15% | 1,051B | |
| +0.70% | +4.01% | +37.80% | +68.27% | 630B | |
| +1.25% | +5.33% | +21.54% | +88.75% | 489B | |
| -0.16% | +4.12% | +69.54% | +40.26% | 359B | |
| +0.61% | +3.18% | +24.10% | +42.46% | 344B | |
| +0.72% | +2.99% | +14.79% | +34.71% | 272B | |
| +0.23% | +2.23% | -5.49% | +8.15% | 246B | |
| +0.30% | +3.14% | +42.14% | +45.82% | 224B | |
| -0.60% | +3.93% | +27.16% | +95.83% | 187B | |
| Average | +0.27% | +2.46% | +28.66% | +54.31% | 380.41B | |
| Weighted average by Cap. | +0.37% | +2.93% | +34.44% | +66.53% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 21.11B 221M 198M 184M 167M 315M 317M 2.21B 867M 10.89B 830M 811M 35.06B | 22.02B 230M 206M 192M 174M 329M 331M 2.31B 904M 11.36B 865M 846M 36.56B |
| Net income | 1.38B 14.39M 12.88M 12.01M 10.89M 20.54M 20.67M 144M 56.48M 710M 54.04M 52.84M 2.28B | 2.53B 26.45M 23.68M 22.07M 20.02M 37.76M 38M 265M 104M 1.3B 99.36M 97.16M 4.2B |
| Net Debt | 3.7B 38.73M 34.67M 32.32M 29.31M 55.29M 55.63M 388M 152M 1.91B 145M 142M 6.15B | 2.11B 22.04M 19.73M 18.39M 16.68M 31.46M 31.66M 221M 86.52M 1.09B 82.79M 80.95M 3.5B |
Employees
2,780
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/10/26 | ₹530.15 | +0.10% | 1,414 |
| 09/10/26 | ₹529.60 | +0.09% | 2,131 |
| 08/10/26 | ₹529.10 | -2.97% | 6,532 |
| 07/10/26 | ₹545.30 | -0.31% | 4,647 |
| 06/10/26 | ₹547.00 | +2.87% | 5,217 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
